The next round of funding
from the Rare Cancers, Rare Diseases and Unmet Need (RCRDUN) Clinical Trials Program will
focus on reproductive cancers: cervical, ovarian, fallopian and testicular.
The funding will support projects of up to three years to drive new ideas and make new discoveries to improve quality of life and survival rates for Australians with these cancers.
More information, including
the grant guidelines, will be available on GrantConnect.